[Federal Register: October 8, 2002 (Volume 67, Number 195)]
[Notices]               
[Page 62727]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08oc02-100]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Dockets No. 02N-0354]

 
Agency Information Collection Activities; Announcement of OMB 
Approval; the Evaluation of Long-Term Antibiotic Drug Therapy for 
Persons Involved in Anthrax Remediation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``The Evaluation of Long-Term 
Antibiotic Drug Therapy for Persons Involved in Anthrax Remediation'' 
has been approved by the Office of Management and Budget (OMB) under 
the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Peggy Schlosburg, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 19, 2002 
(67 FR 53805), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0494. 
The approval expires on March 31, 2003. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: October 1, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-25538 Filed 10-7-02; 8:45 am]
BILLING CODE 4160-01-S